Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Preclinical Therapeutics Development for NeuroAIDS (R21)
Release Date: February 16, 2006
Announcement Number: PA-06-139
Application Receipt Date:
May 1, 2006
Funding Contact: NINDS Funding
Program Area: Neural Environment
Brief Description:
The purpose of this Program Announcement is to encourage the development and/or validation of new in vitro and in vivo models
of HIV or HAART-related neurotoxicity that show promise for use in the screening of novel CNS and PNS-targeted therapeutic
compounds. Ideally, such models would facilitate the screening of compounds or therapeutic approaches which protect neuronal
and glial cells of the CNS from damage in response to HIV and possibly other stresses, such as injury or associated inflammatory
insults.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |